Shares of Fate Therapeutics, Inc. (FATE) were in the spotlight on Monday morning after the company said that the U.S. Food ...

Shares of biopharmaceutical company Soleno Therapeutics, Inc. (SLNO) were in the spotlight on Monday after the company ...

First prescriptions delivered to individuals with PWSREDWOOD CITY, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Soleno ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Eli Lilly and Co. joined several other investors in a Series A round for a Boston biotech co-founded by the Longwood Fund that's developing a drug for a rare type of blood cancer.

Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) traded down 6.7% during mid-day trading on Tuesday ...

Highlights:,Insider transactions have been observed within Soleno Therapeutics, with key executives reducing personal holdings.,Analysts from multiple firms have adjusted their outlook on the company, ...

Soleno Therapeutics, Inc. (NASDAQ:SLNO), a biopharmaceutical company focused on developing and commercializing novel therapeutics for rare diseases, has recently achieved a significant milestone with ...

Soleno Therapeutics, Inc. (NASDAQ:SLNO), a biopharmaceutical company focused on developing and commercializing novel therapeutics for rare diseases, has recently achieved a significant milestone ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other stocks that outperformed broader market last week. Wall Street’s main indices ...